-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$19.33866.5% Upside
Syros Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Syros Pharmaceuticals, Inc.?
Syros Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler, H.C. Wainwright, Oppenheimer in the past 90 days.